Research ExplorerPublicationsDose escalation for metastatic spinal cord compression in pa...

Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors.

Standard

Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors. / Rades, Dirk; Freundt, Katja; Meyners, Thekla; Bajrovic, Amira; Basic, Hiba; Karstens, Johann H; Adamietz, Irenaeus A; Wildfang, Ingeborg; Rudat, Volker; Schild, Steven E; Dunst, Juergen.

In: INT J RADIAT ONCOL, Vol. 80, No. 5, 5, 2011, p. 1492-1497.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Rades, D, Freundt, K, Meyners, T, Bajrovic, A, Basic, H, Karstens, JH, Adamietz, IA, Wildfang, I, Rudat, V, Schild, SE & Dunst, J 2011, 'Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors.', INT J RADIAT ONCOL, vol. 80, no. 5, 5, pp. 1492-1497. <http://www.ncbi.nlm.nih.gov/pubmed/20579816?dopt=Citation>

APA

Rades, D., Freundt, K., Meyners, T., Bajrovic, A., Basic, H., Karstens, J. H., Adamietz, I. A., Wildfang, I., Rudat, V., Schild, S. E., & Dunst, J. (2011). Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors. INT J RADIAT ONCOL, 80(5), 1492-1497. [5]. http://www.ncbi.nlm.nih.gov/pubmed/20579816?dopt=Citation

Vancouver

Rades D, Freundt K, Meyners T, Bajrovic A, Basic H, Karstens JH et al. Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors. INT J RADIAT ONCOL. 2011;80(5):1492-1497. 5.

Bibtex

@article{10f0d729fd05466c9f361dbe2652e78b,
title = "Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors.",
abstract = "Radiotherapy alone is the most common treatment for metastatic spinal cord compression (MSCC) from relatively radioresistant tumors such as renal cell carcinoma, colorectal cancer, and malignant melanoma. However, the results of the {"}standard{"} regimen 30 Gy/10 fractions need to be improved with respect to functional outcome. This study investigated whether a dose escalation beyond 30 Gy can improve treatment outcomes.",
author = "Dirk Rades and Katja Freundt and Thekla Meyners and Amira Bajrovic and Hiba Basic and Karstens, {Johann H} and Adamietz, {Irenaeus A} and Ingeborg Wildfang and Volker Rudat and Schild, {Steven E} and Juergen Dunst",
year = "2011",
language = "English",
volume = "80",
pages = "1492--1497",
journal = "INT J RADIAT ONCOL",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors.

AU - Rades, Dirk

AU - Freundt, Katja

AU - Meyners, Thekla

AU - Bajrovic, Amira

AU - Basic, Hiba

AU - Karstens, Johann H

AU - Adamietz, Irenaeus A

AU - Wildfang, Ingeborg

AU - Rudat, Volker

AU - Schild, Steven E

AU - Dunst, Juergen

PY - 2011

Y1 - 2011

N2 - Radiotherapy alone is the most common treatment for metastatic spinal cord compression (MSCC) from relatively radioresistant tumors such as renal cell carcinoma, colorectal cancer, and malignant melanoma. However, the results of the "standard" regimen 30 Gy/10 fractions need to be improved with respect to functional outcome. This study investigated whether a dose escalation beyond 30 Gy can improve treatment outcomes.

AB - Radiotherapy alone is the most common treatment for metastatic spinal cord compression (MSCC) from relatively radioresistant tumors such as renal cell carcinoma, colorectal cancer, and malignant melanoma. However, the results of the "standard" regimen 30 Gy/10 fractions need to be improved with respect to functional outcome. This study investigated whether a dose escalation beyond 30 Gy can improve treatment outcomes.

M3 - SCORING: Journal article

VL - 80

SP - 1492

EP - 1497

JO - INT J RADIAT ONCOL

JF - INT J RADIAT ONCOL

SN - 0360-3016

IS - 5

M1 - 5

ER -